Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Oncotarget|June 6, 2014
Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumorsChun-Nan Yeh, Chueh-Chuan Yen, Yen-Yang Chen, et al.
Therapeutic Advances in Medical Oncology|November 25, 2021
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based studyTai-Jan Chiu, Yung-Yeh Su, Shih-Hung Yang, et al.
Histopathology|July 30, 2013
HuR cytoplasmic expression is associated with increased cyclin A expression and inferior disease-free survival in patients with gastrointestinal stromal tumours (GISTs)Yu-Ching Wei, Fong-Fu Chou, Chien-Feng Li, et al.
The Journal of Investigative Dermatology|May 8, 2014
Fas/Fas ligand mediates keratinocyte death in sunitinib-induced hand-foot skin reactionChun-Nan Yeh, Wen-Hung Chung, Shih-Chi Su, et al.
American Journal of Cancer Research|May 9, 2022
The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecanShih-Hung Yang, Nai-Jung Chiang, Sz-Chi Chiu, et al.
American Journal of Cancer Research|October 13, 2022
Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorinYen-Yang Chen, Shun-Wen Hsueh, Shih-Hung Yang, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 2, 2024
Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancerCheng-Yu Tang, Shih-Hung Yang, Chung-Pin Li, et al.
Cancer|December 8, 2021
Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patientsHyun Cheol Chung, Yoon-Koo Kang, Zhendong Chen, et al.
Cancers|February 25, 2023
Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic CancerYung-Yeh Su, Nai-Jung Chiang, Yi-Hsin Yang, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|February 19, 2022
Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorinTai-Jan Chiu, Shih-Hung Yang, Sz-Chi Chiu, et al.
Pageof 10